Edition:
United Kingdom

Autolus Therapeutics PLC (AUTL.OQ)

AUTL.OQ on NASDAQ Stock Exchange Global Select Market

21.98USD
21 May 2019
Change (% chg)

-- (--)
Prev Close
$21.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,389
52-wk High
$53.14
52-wk Low
$19.33

Revenue & Earnings Per Share

 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 3 0.10 0.30 0.00 --
Quarter Ending Sep-19 3 0.10 0.30 0.00 --
Year Ending Dec-19 4 1.54 3.00 0.00 --
Year Ending Dec-20 4 0.52 1.10 0.00 --
Earnings (per share)
Quarter Ending Jun-19 4 -0.74 -0.61 -0.94 --
Quarter Ending Sep-19 4 -0.78 -0.61 -1.07 --
Year Ending Dec-19 4 -3.00 -2.53 -3.89 --
Year Ending Dec-20 4 -3.16 -2.59 -4.37 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 97.03 53.45
P/E High - Last 5 Yrs. -- 164.84 57.45
P/E Low - Last 5 Yrs. -- 52.13 28.04
Beta -- 1.19 0.94
Price to Sales (TTM) -- 40.94 9.15
Price to Book (MRQ) -- 11.82 4.14
Price to Tangible Book (MRQ) -- 17.11 4.94
Price to Cash Flow (TTM) -- 63.78 36.55
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.65
Dividend Yield - 5 Year Avg -- 0.05 0.72
Dividend 5 Year Growth Rate -- 0.93 3.10
Payout Ratio(TTM) -- 1.40 15.26

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 58.11 14.75
Sales (TTM) vs TTM 1 Yr. Ago -- 47.38 8.28
Sales - 5 Yr. Growth Rate -- 33.06 10.31
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -10.08 18.46
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 22.32 7.27
Capital Spending - 5 Yr. Growth Rate -- 25.14 8.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.76 2.42
Current Ratio (MRQ) -- 3.79 3.34
LT Debt to Equity (MRQ) -- 7.52 14.28
Total Debt to Equity (MRQ) -- 20.52 19.53
Interest Coverage (TTM) -- 35.45 14.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.42 50.24
Gross Margin - 5 Yr. Avg. -- 55.12 51.07
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -12.83 15.95
Operating Margin (TTM) -- -115.80 -4.72
Operating Margin - 5 Yr. Avg. -- -28.61 11.17
Pre-Tax Margin (TTM) -- -116.03 -4.96
Pre-Tax Margin - 5 Yr. Avg. -- -31.23 15.94
Net Profit Margin (TTM) -- -121.64 -8.76
Net Profit Margin - 5 Yr. Avg. -- -36.25 11.20
Effective Tax Rate (TTM) -- 17.19 20.61
Effective Tax Rate - 5 Yr. Avg. -- 19.00 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 8,975,967 740,344,753
Net Income/Employee (TTM) -- 1,596,651 86,451,148
Receivable Turnover (TTM) -- 11.29 5.63
Inventory Turnover (TTM) -- 2.42 3.63
Asset Turnover (TTM) -- 0.33 0.78

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.05 9.43
Return on Assets - 5 Yr. Avg. -- 6.23 10.42
Return on Investment (TTM) -- 7.44 11.71
Return on Investment - 5 Yr. Avg. -- 8.14 13.28
Return on Equity (TTM) -- 7.90 16.35
Return on Equity - 5 Yr. Avg. -- 9.25 14.84
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Autolus Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -16.44 -14.45 41 7
13 Week -24.62 -26.34 45 16
26 Week -40.19 -43.34 35 10
52 Week -- -- -- 17
YTD -32.98 -40.84 28 10
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 1
Total Shares Held: 147
3 Mo. Net Change: -7
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.